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BACKGROUND: Childhood cancer survival estimates from developing nations are rare.
METHODS: Using the US SEER and the Manila and Rizal Cancer Registry databases in the Philippines, 5-year survival for childhood
leukaemia and lymphoma in 2001–2005 among Asian Americans were compared with both Filipinos and Caucasians in the United
States. Estimates for patients in the United States in earlier time periods were compared with that of Philippine residents to estimate
delay in achievements of comparable levels of survival.
RESULTS: Childhood leukaemia and lymphoma relative survival was much lower in Filipinos living in the Philippines (32.9 and 47.7%)
than in Asian Americans (80.1 and 90.5%) and Caucasians (81.9 and 87%). Achievement of comparable survival rates of Philippine
residents lagged behind by 20 to 430 years compared with patients in the United States.
CONCLUSIONS: The large differences in survival estimates of US populations and Philippine residents highlight the deficiencies of
paediatric cancer care delivery in the Philippines. The long survival lag underlines the need for major improvements in access to
diagnostic and treatment facilities.
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Childhood cancer survival rates vary in different countries and
ethnicities (Stiller et al, 2000; Bhatia et al, 2002; Gatta et al, 2002,
2003; Kadan-Lottick et al, 2003; Aplenc et al, 2006; Brenner et al,
2007; Linabery and Ross, 2008). Nevertheless, international (Gatta
et al, 2002, 2003; Brenner et al, 2007) and ethnic (Stiller et al, 2000;
Bhatia et al, 2002; Kadan-Lottick et al, 2003; Aplenc et al, 2006;
Linabery and Ross, 2008) comparisons are relatively few,
particularly with low-income countries, mainly because of the
absence of data.
Survival comparisons between countries and ethnic groups are
important to assess the magnitude of survival discrepancies and to
examine the possible sources of variability. By comparing survival
estimates of developing countries with those from developed
nations along time periods, delay in achieving comparable survival
levels can be quantified.
In this study, we provide up-to-date estimates of childhood
leukaemia and lymphoma survival for the Philippine resident
population and Asian Americans, who have similar ethnicity, and
Asian Americans and Caucasians from the United States, who have
the same health-care system. To quantify delay in survival and
determine lag time, 5-year estimates for various time periods
between 1976–1980 and 2001–2005 were computed for children in
the United States, and compared with the 2001–2005 survival
estimates for Philippine residents.
MATERIALS AND METHODS
US data were abstracted from the database of the Surveillance,
Epidemiology and End Results (SEER) Program Limited-Use Data
(1973–2005) (SEER, 2008), which routinely collects data on cancer
patients from selected populations in the United States. For this
analysis, the SEER 9 and 17 databases were used. From the SEER
17 database, patients 0–14 years of age, of either Asian-American
or Caucasian origin, diagnosed with leukaemia or lymphoma
based on the International Classification of Childhood Cancer
(ICCC) definition (Steliarova-Foucher et al, 2005) between
1 January 1996 and 31 December 2005 were included. Death
certificate only (DCO), in situ and autopsy cases were excluded.
A total of 625 Asian-American and 6834 Caucasian children were
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lymphoma cases from the former, and 5344 (78%) leukaemia and
1490 (22%) lymphoma cases, from the latter group. In this study,
Filipino Americans were combined with other Asian-American
groups, because of their small numbers. From the SEER 9 database,
patients 0–14 years of age, regardless of race, and diagnosed with
ICCC classified leukaemia or lymphoma between 1 January 1976
and 31 December 2005 were included. DCO, in situ and autopsy
cases were likewise excluded, leaving 6913 leukaemia and 2253
lymphoma cases for the analysis.
The databases used in the analyses of the Philippine resident
population came from the Philippine Cancer Society–Manila
Cancer Registry (PCS–MCR) and the Department of Health–Rizal
Cancer Registry (DOH–RCR). These registries cover the National
Capital Region (NCR), more commonly known as Metro Manila,
which is the largest urban metropolis, and the political, social,
educational and economic centre. This population is wealthier
and has better access to health-care and cancer diagnostic and
treatment facilities than the rest of the country (NSCB, 2006).
The Philippine registries follow the cancer registration
definitions and data collection guidelines set by the International
Agency for Research on Cancer and the International Association
of Cancer Registries. They are regarded as among the high-
quality cancer registries from developing countries and have
been regularly included in Cancer Incidence in Five Continents
(Muir et al, 1987; Parkin et al, 1992, 1997, 2002; Curado et al,
2007).
From a list of patients diagnosed between 1 January 1996 and
31 December 2005, subjects were selected using the same inclusion
and exclusion criteria as for the SEER 17 database. Survival status
was assessed from death certificate notifications mentioning
cancer as the cause of death, which were collected from the Local
Civil Registry Offices. For those not identified as dead, active
follow-up by personal visits to the patients or their families in the
last known place of residence was used to confirm vital status.
From the 1500 childhood leukaemia and lymphoma cases
registered in the PCS–MCR and DOH–RCR databases, 4 (o1%)
were excluded because of invalid data, and 232 (16%) because of
missing follow-up information. A total of 1264 (84%) patients were
left in the analysis, for whom anonymised data sets were prepared.
Of the cases, 86% (1081) had leukaemia while the remaining 14%
(183) had lymphoma.
The project proposal was approved by the ethics review board
of the National Institutes of Health of the University of the
Philippines Manila. The information obtained strictly conformed
to the code of conduct stipulated by the Guidelines on
Confidentiality for Population-Based Cancer Registries (Inter-
national Association of Cancer Registries & International Agency
for Research on Cancer, 2004).
Data analysis
In this study, period analysis of survival analysis was used
(Brenner and Gefeller, 1996). With this approach, only the survival
experience of patients for the 2001–2005 period was included. It
has been shown that period analysis provides more up-to-date
estimates of survival that closely predict survival later observed for
patients diagnosed in the relevant period (Brenner et al, 2002;
Brenner and Hakulinen, 2002a,b; Ta ¨lback et al, 2004; Ellison, 2006;
Steliarova-Foucher et al, 2007). Analyses were carried out by types
of leukaemia ((Ia) ALL, (Ib) acute myeloid (AML), and other
types, including (Ic) chronic myeloproliferative diseases, (Id)
myelodysplastic syndrome and other myeloproliferative diseases
and (Ie) unspecified and other leukaemias) and lymphomas ((IIa)
Hodgkins (HL), (IIb) non-Hodgkin (NHL), and other types,
including (IIc) Burkitt, (IId) miscellaneous lymphoreticular
neoplasms and (IIe) unspecified lymphomas) (Steliarova-Foucher
et al, 2005), by sex and by age (o1, 1–4, 5–9 and 10–14).
Owing to small sample sizes for the other subtypes, only the survival
estimates for ALL, AML and NHL were separately computed.
Estimates of relative survival (calculated as the ratio of observed
and expected survival) were derived using the so-called Ederer II
method (Ederer and Heise, 1959) and life tables for the year 2000.
Owing to the absence of life tables for other races, the life table
for whites from the US National Center for Health Statistics
(Arias, 2002) was used for both SEER populations. The life table
for the Philippine resident population was derived from the
projected population estimate and the actual mortality data for
this area, obtained from the Philippine National Statistics Office.
To compare overall survival estimates between the different cancer
populations, age was adjusted using the distribution of
the Filipinos patients. The age groups used were o1, 1–4, 5–9
and 10–14.
To test for differences in survival between the ethnic groups,
a novel modelling approach for period analysis (Brenner and
Hakulinen, 2006) was used. First, age-specific numbers of patients
at risk and of deaths by year of follow-up were calculated
separately for each population group. Then, Poisson regression
models were fitted, in which the numbers of deaths were modelled
as a function of the group (Philippine residents or Asian
Americans or US Caucasians) and year of follow-up (1, 2, 3,
4, 5 – entered as a categorical variable), using the logarithm of the
person-years at risk as offset, and accounting for late entries and
withdrawals as half persons, as described in detail elsewhere
(Brenner and Hakulinen, 2006). In models for all types of
leukaemia and lymphoma (both sexes and separately for men
and women), and for ALL, AML and NHL, we also included
age groups. This approach allowed testing for significance of
differences in survival, after accounting for differences in distri-
bution of subgroups, based on P-values for the population
parameter estimate. A significance level of ¼0.05 (two-sided
testing) was used.
Using the SEER 9 database, period survival estimates for the
years 1976–1980, 1981–1985, 1986–1990, 1991–1995, 1996–2000
and 2001–2005 were derived for children in the United States,
using the same algorithms used for the Philippine residents, Asian
Americans and US Caucasians. These survival estimates were then
compared with those for the Philippine population in 2001–2005,
using only the data from the SEER 9 registries, as these have
information dating back to the early 1970s. The other SEER
registries were only included in the programme in the 1990s and
2001 (National Cancer Institute, September 2005).
RESULTS
In all three populations and in both sexes, a majority of leukaemia
cases were diagnosed as ALL (Table 1), whereas NHL was the
commonest lymphoma subtype. However, the proportion of
leukaemia patients with ALL was lower, and of patients with
undifferentiated leukaemias and AML was higher in the Philippine
resident population than in the United States (Po0.0001).
Among lymphoma patients, the proportion of children with HL
was lower, and the proportion of children with other types
of lymphoma was larger in Philippine residents (Po0.0001).
More men were diagnosed than women in all groups for both types
of malignancies. For leukaemias, the differences in age distri-
bution between the three populations were not large (Table 2).
For lymphomas, while most cases were older than 5 years in all
groups, Philippine residents were relatively younger than the SEER
populations, with a larger proportion (29.5%) of cases aged 4 years
and below.
Age-adjusted, and type-, age- and sex-specific estimates of
5-year absolute and relative survival for the 2001–2005 period
are shown in Table 3. Much lower leukaemia relative survival was
observed in Filipinos living in the Philippines (32.9%) than in
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ALL have better survival than those with AML for all populations,
but this advantage is small among Philippine residents. Survival
estimates for men are slightly higher than for women in all three
groups. Stratification by age reveals that the survival disadvantage
of Philippine residents is particularly large for age group
10–14 years, where 5-year relative survival was as low as 17.6%.
For lymphoma, and NHL in particular, relative survival estimates
for Philippine residents were likewise much lower (47.7 and 49.7%,
for lymphoma and NHL, respectively) than the US populations
(90.5 and 84.8% for Asian Americans, and 87.0 and 81.0% for
Caucasians).
Trends in 5-year survival for childhood leukaemia and
lymphoma cases in the United States between 1976–1980 and
2001–2005 is shown in Table 4. For all groups, rates strongly
increased over time, with improvements between the 1976–1980
and 2001–2005 periods ranging from 25 to 40%. When compared
with Philippine residents, survival estimates for patients from the
Philippines in 2001–2005 were even lower than those for the US
populations in 1976–1980, with the exception of AML, for which
survival in the Philippines in 2001–2005 was similar to that for
American children in 1981–1990.
DISCUSSION
In this comparative analysis of childhood leukaemia and
lymphoma in 2001–2005, a strong survival disadvantage was
observed for Philippine residents as compared with US children,
while survival among Asian-American and Caucasian children was
similar. Although estimates for Philippine children were expected
to be lower than US patients, a lag in achievement of comparable
survival rates of 20 to 430 years is disappointing. These survival
rates highlight the deficiencies of paediatric cancer care in the
Philippines, including unavailability of and inadequate access to
diagnostic and treatment facilities, financial difficulties and lack of
awareness.
Table 1 Tumour characteristics of childhood leukaemia and lymphoma patients among the Philippine resident population and Asian Americans and
Caucasians from US SEER, 1996–2005
Philippine resident population Asian American Caucasians
Sex Type of malignancy Freq % Freq % Freq % P-value
Both sexes Leukaemia 1081 496 5344 o0.0001
ALL 699 64.7 376 75.8 4350 81.4
AML 252 23.3 93 18.8 789 14.8
Other types 130 12.0 27 5.4 205 3.8
Lymphoma 183 129 1490 o0.0001
HL 21 11.5 34 26.4 607 40.7
NHL 85 46.5 65 50.4 607 40.7
Other types 77 42.1 30 23.3 276 18.5
Males Leukaemia 639 285 2963 o0.0001
ALL 429 67.1 220 77.2 2417 81.6
AML 135 21.1 51 17.9 426 14.4
Other types 75 11.7 14 4.9 120 4.1
Lymphoma 120 86 963 o0.0001
HL 15 12.5 23 26.7 353 36.7
NHL 59 49.2 40 46.5 385 40.0
Other types 46 38.3 23 26.7 225 23.4
Females Leukaemia 442 211 2381 o0.0001
ALL 270 61.1 156 73.9 1933 81.2
AML 117 26.5 42 19.9 363 15.3
Other types 55 12.4 13 6.2 85 3.6
Lymphoma 63 43 527 o0.0001
HL 6 9.5 11 25.6 254 48.2
NHL 26 41.3 25 58.1 222 42.1
Other types 31 49.2 7 16.3 51 9.7
Abbreviations: ALL¼acute lymphoblastic leukaemia; AML¼acute myeloblastic leukaemia; HL¼Hodgkin lymphoma; NHL¼non-Hodgkin lymphoma; SEER¼surveillance,
epidemiology and end results.
Table 2 Childhood leukaemia and lymphoma patients among the
Philippine resident population and Asian Americans and Caucasians from
US SEER, 1996–2005, by age group
Philippine
resident
population
Asian
American Caucasians
Age group Freq % Freq % Freq % P-value
Leukaemia 1081 496 5344 0.009
o1 67 6.2 34 6.9 319 6.0
1–4 457 42.3 249 50.2 2527 47.3
5–9 349 32.3 127 25.6 1455 27.2
10–14 208 19.2 86 17.3 1043 19.5
ALL 699 376 4350 o0.001
o1 38 5.4 18 4.8 142 3.3
1–4 315 45.1 206 54.8 2211 50.8
5–9 234 33.5 96 25.5 1241 28.5
10–14 112 16.0 56 14.9 756 17.4
Lymphoma 183 129 1490 o0.0001
o1 2 1.1 2 1.6 10 0.7
1–4 52 28.4 26 20.2 190 12.8
5–9 52 28.4 32 24.8 449 30.1
10–14 77 42.1 69 53.5 841 56.4
Abbrevaitions: ALL¼acute lymphoblastic leukaemia; SEER¼surveillance, epidemio-
logy and end results.
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ment modalities, such as immunophenotyping, cytogenetics, linear
accelerator, MRI and PET–CT scan are present, these are
inaccessible to most of the population. Services are available in
paediatric oncology sections of large tertiary hospitals, which are
few, mainly situated in major cities, and sometimes understaffed.
Although there are adequate numbers of paediatric haematologists
or oncologists in the country, there is no certified paediatric cancer
unit (Ribeiro et al, 2008). A majority of the institutes and hospitals
do not have full time paediatric haematologists–oncologists
and specialised paediatric oncology nurses (Corrigan and Feig,
2004). Outside these units, diagnostic testing was described as
nonexistent to limited, with a long wait for results at best, and
availability of medications and blood products were limited or
irregular, making supportive care for cancer patients poor
(Ribeiro et al, 2008).
The expensive nature of paediatric cancer care further
complicates the problem of inadequate health services and staff.
The Philippines has a 2008 Gross National Income per capita of
USD 3900 as compared with USD 46970 for the United States
(World Bank, 2009). Although a national health-care insurance,
PhilHealth, was introduced in 1997, its coverage is limited and
most patients are not enrolled. Moreover, most patients cannot
start treatment, and for those who do, treatment abandonment is
common. In contrast, almost all children with cancer in the United
States are treated in highly specialised paediatric oncology centres,
which are a part of a national children oncology group.
Furthermore, a special insurance programme covering children
with serious illnesses, including cancer, is available (Centers for
Medicare and Medicaid Services, 2009), resulting in a lower
frequency of treatment discontinuation.
Lack of awareness is an important issue in the Philippines,
especially on health problems relating to children, which leads to
delays in seeking medical help and treatment (Usmani, 2001). Owing
to the nonspecificity of signs and symptoms of early childhood
leukaemia and lymphoma, most patients from deve-
loping countries are diagnosed at a later stage. For example, data
from the Philippine General Hospital show that 55.3% of newly
diagnosed paediatric charity ALL cases diagnosed in 2003–2007 were
high risk by US National Cancer Institute criteria, with more than half
having an initial white blood cell count 450000 (Lubaton et al,
2009). Furthermore, 71% of newly diagnosed solid tumour patients in
2008 presented at stages III and IV. Similarly, inadequate education
and poverty compel some parents to turn to traditional and
alternative medicines for treatment (Usmani, 2001; Arora et al, 2007).
Similar survival estimates were observed between Asian
Americans and Caucasians, consistent with previous findings
(Kadan-Lottick et al, 2003). This could be attributed to the high
Table 3 Five-year survival (in %) of childhood leukaemia and lymphoma patients, Philippine resident population and Asian Americans and Caucasians from
US SEER, 2001–2005
(1) Philippine resident population Between (1) and (2) (2) Asian American Between (3) and (2) (3) Caucasians
Variable % s.e. Diff P-value % s.e. Diff P-value % s.e.
Absolute survival
Leukaemias
Overall
a 32.3 2.6 47.7 o0.001 80.0 2.6 1.7 0.39 81.7 0.7
By type
a
ALL 33.8 3.1 53.3 o0.001 87.2 2.4  1.1 0.9993 86.1 0.7
AML 28.2 5.7 33.5 o0.001 61.8 7.5  2.0 0.86 59.7 2.5
By sex
a
Male 35.6 3.5 46.3 o0.001 81.9 3.5  0.6 0.83 81.2 1.0
Female 27.3 3.8 51.0 o0.001 78.3 3.8 3.8 0.12 82.1 1.1
By age group
o1 29.0 10.3 31.5 0.02 60.5 11.9  3.0 0.72 57.4 3.7
1–4 37.8 4.3 44.2 o0.001 82.0 3.6 6.5 0.08 88.5 0.9
5–9 34.7 4.5 45.7 o0.001 80.4 5.0 1.9 0.43 82.3 1.4
10–14 17.5 4.7 63.8 o0.001 81.3 5.6  7.6 0.53 73.7 1.9
Lymphomas
Both sexes
a 47.1 6.1 43.2 o0.001 90.3 2.6  3.5 0.99 86.9 1.4
NHL
a 49.1 9.3 35.6 o0.01 84.7 4.9  3.9 0.85 80.8 2.1
Relative survival
Leukaemias
Overall
a 32.9 2.6 47.3 o0.001 80.1 2.6 1.7 0.38 81.9 0.7
By type
a
ALL 34.4 3.1 52.9 o0.001 87.3 2.4  1.1 0.995 86.2 0.7
AML 28.5 5.7 33.3 o0.001 61.9 7.5  2.0 0.86 59.8 2.5
By sex
a
Male 36.2 3.6 45.8 o0.001 82.0 3.5  0.6 0.83 81.4 1.0
Female 27.6 3.8 50.8 o0.001 78.4 3.8 3.8 0.12 82.2 1.1
By age group
o1 30.3 10.7 30.6 o0.001 60.9 12.0  3.1 0.26 57.9 3.7
1–4 38.7 4.4 43.4 o0.001 82.1 3.6 6.5 0.43 88.6 0.9
5–9 34.8 4.5 45.6 o0.001 80.4 5.0 1.9 0.43 82.3 1.4
10–14 17.6 4.7 63.9 o0.001 81.5 5.6  7.6 0.53 73.8 1.9
Lymphomas
Both sexes
a 47.7 6.2 42.7 o0.001 90.5 2.6  3.5 0.98 87.0 1.4
NHL
a 49.7 9.4 35.1 o0.01 84.8 4.9  3.8 0.85 81.0 2.2
Abbreviations: ALL¼acute lymphoblastic leukaemia; AML¼acute myeloblastic leukaemia; NHL¼non-Hodgkin lymphoma; SEER¼surveillance, epidemiology and end results.
aAdjusted to the age distribution of the leukaemia/lymphoma of the patients from the Philippines.
Childhood leukaemia and lymphoma comparisons
MT Redaniel et al
152
British Journal of Cancer (2010) 103(1), 149–154 & 2010 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
ylevel of health-care access among Asian Americans, the majority
of whom being either native born (31%) or naturalised citizens
(34%) (Reeves and Bennett, 2004). Moreover, Asian Americans
have higher earnings than the average American, with a large
proportion having attained a bachelor’s degree or more (44%),
and more likely to be in management, professional or related
occupations (45%) (Reeves and Bennett, 2004).
Taken together, our results underline the overwhelming
importance of access to effective treatment as accounting for the
observed survival differences between the populations studied.
Even though some ethnic variability has been observed, under trial
conditions with identical treatment and access (Aplenc et al, 2006),
this variation was small compared with the huge variation
according to the health-care system in our study.
Some limitations of our study are relevant because not all
factors that could affect survival could be considered. Information
not obtainable include factors related to cancer services, such
as training and skills of health-care professionals, accuracy of
diagnostic tests, chemotherapy protocols used, and disease
characteristics such as cancer stage, and comorbidities. Further-
more, in spite of exhaustive measures to locate Philippine resident
for survival information, including personal visits to the homes,
follow-up was in complete for 25% of patients, attributable to the
high migration and mobility in the study area. Nevertheless, it can
be assumed that patients lost to follow-up have not received or
have discontinued treatment, as follow-up information was not
found or incomplete in hospitals within the NCR. The availability
of cancer treatment is limited in the surrounding regions and it is
unlikely that patients lost to follow-up have higher survival than
those who were not.
In spite of these limitations, our results highlight the very
large survival disadvantage of children in the Philippines.
Efforts such as more twinning programmes between hospitals
and specialised centres in developed and developing countries
should be considered, as well as increased government spending
on health, which have been shown to be effective in enhancing care
of childhood leukaemia in developing countries (Pui and Ribeiro,
2003; Howard et al, 2004).
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Table 4 Five-year survival (in %) of childhood leukaemia and lymphoma patients, US SEER 9, 1976–2005
1976–1980 1981–1985 1986–1990 1991–1995 1996–2000 2001–2005
Variable % s.e. % s.e. % s.e. % s.e. % s.e. % s.e.
Absolute survival
Leukaemias
Overall
a 52.7 2.7 60.7 1.6 66.5 1.4 72.3 1.3 79.1 1.2 82.9 1.1
By type
a
ALL 60.7 3.1 67.4 1.7 74.2 1.5 79.1 1.4 85.6 1.1 88.1 1.0
AML 20.7 4.8 29.4 4.4 35.8 4.4 40.5 3.8 48.9 3.7 60.7 3.7
By sex
a
Male 49.4 3.9 58.1 2.2 64.1 1.9 71.0 1.8 77.9 1.6 82.6 1.4
Female 56.1 3.7 62.2 2.2 69.3 2.1 73.8 1.9 81.1 1.7 83.5 1.6
By age group
o1 8.7 10.5 28.0 6.3 27.0 5.2 46.2 6.5 52.0 6.5 64.1 5.5
1–4 64.3 4.5 68.4 2.2 76.4 1.9 78.4 1.7 87.4 1.4 89.3 1.3
5–9 53.2 5.0 67.3 3.0 72.2 2.7 74.4 2.4 82.0 2.1 83.6 2.0
10–14 40.5 4.7 43.2 3.5 48.0 3.5 63.5 3.5 64.7 3.2 73.7 2.9
Lymphomas
Both sexes
a 60.9 3.8 72.6 2.8 76.1 2.6 84.2 2.1 84.8 2.2 88.7 1.8
NHL
a 54.4 6.1 65.4 4.4 75.0 3.8 74.4 3.8 81.7 3.2 84.5 2.6
Relative survival
Leukaemias
Both sexes
a 52.8 2.8 60.8 1.6 66.6 1.4 72.4 1.3 79.2 1.2 83.0 1.1
By type
a
ALL 60.8 3.1 67.5 1.7 74.3 1.5 79.2 1.4 85.7 1.2 88.2 1.0
AML 20.7 4.8 29.5 4.4 35.8 4.4 40.5 3.8 49.0 3.7 60.8 3.7
By sex
a
Male 49.5 3.9 58.2 2.2 64.2 1.2 71.1 1.8 78.1 1.6 82.7 1.4
Female 56.2 3.7 62.3 2.2 69.4 2.1 73.9 1.9 81.2 1.7 83.6 1.6
By age group
o1 8.8 10.5 28.2 6.3 27.2 5.2 46.6 6.6 52.4 6.6 64.6 5.5
1–4 64.4 4.5 68.5 2.2 76.5 1.9 78.5 1.7 87.6 1.4 89.4 1.3
5–9 53.3 5.0 67.4 3.0 72.3 2.7 74.5 2.4 82.1 2.1 83.6 2.0
10–14 40.6 4.7 43.2 3.5 48.1 3.5 63.6 3.5 64.8 3.2 73.9 2.9
Lymphomas
Both sexes
a 61.0 3.8 72.7 2.8 76.2 2.6 84.3 2.1 84.9 2.2 88.8 1.8
NHL
a 54.4 6.1 65.5 4.5 75.1 3.8 74.5 3.8 81.8 3.2 84.6 2.6
Abbreviations: ALL¼acute lymphoblastic leukaemia; AML¼acute myeloblastic leukaemia; NHL¼non-Hodgkin lymphoma; SEER¼surveillance, epidemiology and end results.
aAdjusted to the age distribution of the leukemia/lymphoma of the patients from the Philippines.
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